Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

The pharmaceutical giant <keyword id="19910149" type="General" weightage="20" keywordseo="AstraZeneca" source="keywords" meta.keywordsubtype="org" meta.entityname="AstraZeneca" meta.hostid="261" meta.entityid="AstraZeneca">AstraZeneca</keyword>'s <keyword id="20040659" type="General" weightage="20" keywordseo="COVID-19-vaccine" source="keywords">COVID-19 vaccine</keyword> is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. AstraZeneca has announced that the <keyword id="19959412" type="General" weightage="20" keywordseo="vaccine" source="keywords">vaccine</keyword> was being removed from markets for commercial reasons. It further said that the vaccine was no longer being made or supplied, having been superseded by updated vaccines that fight new variants. The application to withdraw the vaccine was made on March 5 and came into effect on May 7. The vaccine can be no longer used in the European Union following the company's decision to withdraw its "marketing authorisation." Similar applications will be submitted in the UK and other nations in the coming months that have given a go-ahead to the vaccine, known as Vaxzevria. In recent months, Vaxzevria has come under scrutiny over a very rare side effect, which causes blood clots and low blood platelet counts. In court documents, AstraZeneca in the High Court in February admitted that the vaccine "can, in very rare cases, cause <keyword id="20218859" type="General" weightage="20" keywordseo="TTS" source="keywords">TTS</keyword>". TTS which stands for <keyword id="21475609" type="General" weightage="20" keywordseo="Thrombosis-with-Thrombocytopenia-Syndrome" source="keywords">Thrombosis with Thrombocytopenia Syndrome</keyword> has been associated with at least 81 deaths in the UK and hundreds of serious injuries. More than 50 alleged victims and grieving relatives have filed a lawsuit against AstraZeneca in a High Court case. AstraZeneca has insisted that the decision to withdraw the vaccine is not related to the case or admission that it can cause TTS and termed the timing a pure coincidence, according to The Telegraph report. "We are incredibly proud of the role Vaxzevria played in ending the global pandemic. According to independent estimates, over 6.5 million lives were saved in the first year of use alone and over three billion doses were supplied globally. Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic," The Telegraph quoted AstraZeneca as saying. In a statement, the pharmaceutical giant said, "As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines", adding that it has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied, The Telegraph reported. It further announced its decision to initiate the withdrawal of the marketing authorisations for Vaxzevria within Europe. The company said, "We will now work with regulators and our partners to align on a clear path forward to conclude this chapter and significant contribution to the Covid-19 pandemic." Last week, AstraZeneca reiterated its commitment to patient safety while emphasising the vaccine's overall safety profile. An AstraZeneca spokesperson had stated, "Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines." This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its <keyword id="19896627" type="General" weightage="20" keywordseo="covid" source="keywords">Covid</keyword> vaccine Covishield and Vaxzevria "can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS)." Despite these rare occurrences, the pharmaceutical company maintained that extensive clinical trial data and real-world evidence consistently support the vaccine's safety and efficacy. Regulatory agencies worldwide continue to assert that the benefits of vaccination outweigh the risks of such extremely rare side effects. SEE ALSO:<a href="https://www.businessinsider.in/stock-market/webstories/aadhar-housing-finance-ipo-price-band-to-risk-factors-all-you-need-to-know/slidelist/109919298.cms" target="_blank"></a> <a href="https://www.businessinsider.in/stock-market/webstories/aadhar-housing-finance-ipo-price-band-to-risk-factors-all-you-need-to-know/slidelist/109919298.cms" target="_blank">Aadhar Housing Finance IPO – Price band to risk factors, all you need to know</a><a href="https://www.businessinsider.in/business/auto/webstories/top-selling-cars-in-india-in-april-2024-tata-punch-continues-to-dominate/slidelist/109909744.cms" target="_blank"></a> <a href="https://www.businessinsider.in/business/auto/webstories/top-selling-cars-in-india-in-april-2024-tata-punch-continues-to-dominate/slidelist/109909744.cms" target="_blank">Top-selling cars in India in April 2024 – Tata Punch continues to dominate</a><a href="https://www.businessinsider.in/tech/news/worldwide-tablet-shipments-grow-in-q1-2024-after-two-years-of-decline/articleshow/109876390.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/news/worldwide-tablet-shipments-grow-in-q1-2024-after-two-years-of-decline/articleshow/109876390.cms" target="_blank">Worldwide tablet shipments grow in Q1 2024 after two years of decline</a>

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

<ul class="summary-list"><li>The US Army is telling soldiers kicked out over COVID-19 vaccinations that they can come back.</li><li>The Army missed its recruiting goal by about 25% in 2022.</li></ul>The US Army is <a target="_blank" href="https://www.businessinsider.com/army-trains-recruits-who-fail-initial-standards-during-recruitment-crisis-2022-7">having such a difficult time recruiting</a> that it's sending soldiers who were kicked out for refusing to get vaccinated against COVID-19 instructions on how to rejoin.The Army sent the letters to about 1,900 active-duty soldiers who were separated for refusing to get vaccinated against COVID-19, according to the military blog <a target="_blank" href="https://taskandpurpose.com/news/army-covid-vaccine-mandate-reversal/">Task and Purpose</a>. Bryce Dubee, an Army spokesperson, told the blog that the letters were sent "specifically as part of the COVID mandate recession process."A January 2023 <a target="_blank" href="https://media.defense.gov/2023/Jan/10/2003143118/-1/-1/1/SECRETARY-OF-DEFENSE-MEMO-ON-RESCISSION-OF-CORONAVIRUS-DISEASE-2019-VACCINATION-REQUIREMENTS-FOR-MEMBERS-OF-THE-ARMED-FORCES.PDF">Department of Defense memo</a> rescinded the military rules that required service members to get vaccinated against COVID-19, which the department put in place in August and November 2021. The memo said that no one serving in the armed forces will be separated for refusing to take the vaccine if they seek a religious, administrative, or medical accommodation.Still, the memo said that the department will continue to "promote and encourage" vaccination for all service members.The <a target="_blank" href="https://www.reddit.com/media?url=https%3A%2F%2Fi.redd.it%2Fletter-of-return-to-service-v0-8v09ym5mht0c1.jpg%3Fs%3Da8ae6a9b332a1018a514242d6f666acf1d93e3d5&amp;rdt=46698">letter</a>, which has been circulated on social media, says former soldiers who were separated for refusing to take the vaccine can request a correction of their military record and instructs those who wish to rejoin to contact a recruiter.The new outreach to these soldiers comes amid a recruiting crisis for the US military. In 2022, the Army fell short of its recruiting goal by about 15,000 soldiers, or 25%, <a target="_blank" href="https://www.armytimes.com/news/your-army/2022/10/02/army-misses-recruiting-goal-by-15000-soldiers/">Army Times</a> reported.The Army recently revived its classic "<a target="_blank" href="https://www.youtube.com/watch?v=Lwx-2R9swDg">Be All You Can Be</a>" <a target="_blank" href="https://www.youtube.com/watch?v=Lwx-2R9swDg">campaign</a> to combat its constant decline in recruits, according to <a target="_blank" href="https://www.npr.org/2023/10/05/1203766333/us-army-military-recruit-pentagon-air-force-navy">NPR</a>.Secretary of the Army Christine Wormuth told the outlet that the percentage of young Americans who are physically fit and mentally prepared enough to join the military has been shrinking over time and is now at about 23% of people between the ages of 18 and 24.Wormuth also said that younger people are not as interested in joining the military due to institutional skepticism."When you look at Generation Z, you see a lot of the declining trust in institutions," Wormuth told NPR.The US Army did not immediately return a request for comment from Business Insider Saturday.

The US Army is having a hard time recruiting. Now it's asking soldiers dismissed for refusing the COVID-19 vaccine to come back.

You Searched For "covid19 vaccine" and got 2 results

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

ANI

The US Army is having a hard time recruiting. Now it's asking soldiers dismissed for refusing the COVID-19 vaccine to come back.

Kenneth Niemeyer

Popular Keywords

Buying Guides